SR-Exenatide (PT320)

Exenatide derivative PT320 · Peptron, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SR-Exenatide (PT320), covering 2021-04-12 to 2021-04-12. Get the full timeline:

Most recent: Clinical Trial Update: SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease [Phase 2]